OssDsign Announces FDA 510(k) Clearance of OSSDSIGN® Cranioplug

OssDsign AB, the Swedish designer, manufacturer and distributor of regenerative implants for cranial and facial reconstruction, today announced that it has received 510(k) clearance by the US FDA for marketing and sale of its latest product, OSSDSIGN® Cranioplug.  OSSDSIGN® Cranioplug is an…

Major Cranial Reconstruction Using OssDsign Technology: Case Report Published in Journal of Neurosurgery

On September 14, the renowned Journal of Neurosurgery published a case report of a patient operated at Uppsala University Hospital in June 2017. As reported previously in Swedish media, the case involved removal of more than 70% of the patient’s…

OssDsign Accelerates Commercial Efforts in the US

OssDsign is active on the US neurosurgical implants market with its lead product OSSDSIGN Cranial PSI, a calcium-phosphate based implant for cranioplasty. Since March 2017, OssDsign has a commercial partnership with California-based Matador Medical Inc who acts as master distributor…

Swedish Research Provides Solution for Untreatable Patients

Swedish Research Provides Solution for Untreatable Patients

The patient, who arrived in Uppsala in early 2017, suffered from a tumor which had infiltrated the skull over the course of five years and penetrated through the cranium. The patient underwent surgery twice in June, during which a majority…

OssDsign Announces Agreement for Distribution of OSSDSIGN Cranial in the USA with Matador Medical Inc.

​OssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for cranial and facial reconstruction, today announced that it has signed an agreement with Matador Medical Inc. to act as its master distributor in the US market. OssDsign…

OssDsign Announces FDA 510(k) Clearance of OSSDSIGN® Cranial for Sale in the USA

​OssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for cranial and facial reconstruction, today announced that it has received 510(k) clearance by the US FDA for marketing and sale of OSSDSIGN® Cranial PSI in the USA.​​ Anders…

Senior Real Estate Specialist (SRES®) Announces New Complimentary Seminar: 3 Smart Real Estate Options for Baby Boomers and Beyond

​With the New Year, now is the perfect time to get educated and evaluate smart real estate decisions. Austin, Texas Seniors Real Estate Specialist (SRES®) Karen Doscher has announced a new FREE Seminar on January 28, from 1 p.m. to…

OssDsign Announces New Partnerships for Commercialisation of Its Novel Medical Implants in Europe

OssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for cranial and facial reconstruction, today announced it has entered new commercial partnerships covering distribution of its products in Italy, Spain, Switzerland, Austria and The Netherlands. OssDsign‘s lead products…

Sleeptember® Invites All to Pledge to Improve Sleep and Engage, Learn, Share and Give

Sleeptember® Invites All to Pledge to Improve Sleep and Engage, Learn, Share and Give

People know very little about how they spend a third of their lives. Sleeptember® is a new year-round campaign and community designed to create fun and engaging online and community events in order to raise awareness of the public health…

Anti-Snoring Devices and Snoring Surgery Market Worth 1,232.6 Million USD by 2020

The report “Anti-snoring Devices and Snoring Surgery Market by Device Type (MADs, TRD, Nasal Dilator, Chin Strap, Position Control, Pillows, TSD, EPAP), Surgical Procedure (UP3, LAUP, RFA, Sclerotherapy, Pillar, Others (Septoplasty, ESS)) - Global Trends & Forecast to 2020” analyzes…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Or form here

Already have an account ? Login

Reset Password

Already have an account ? Login